Fig. 2From: Safety, efficacy and biomarkers analysis of mesenchymal stromal cells therapy in ARDS: a systematic review and meta-analysis based on phase I and II RCTsRisk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studiesBack to article page